Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label VTE. Show all posts
Showing posts with label VTE. Show all posts
Tuesday, April 24, 2012

U of Michigan: Outpatient surgery patients also at risk for dangerous blood clots | University of Michigan Health System

›
  Outpatient surgery patients also at risk for dangerous blood clots | University of Michigan Health System "...With the information...
Thursday, April 19, 2012

abstract: Postoperative venous thromboembolism predicts survival in cancer patients

›
Postoperative venous thromboembolism predicts survi... [Ann Surg. 2012] OBJECTIVES: To determine whether a postoperative venous thromboe...
Wednesday, April 04, 2012

Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients

›
Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients : Background: Patients with active cancer are oft...
Saturday, March 03, 2012

abstract - EvidenceUpdates: Cochrane Review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy (including professional commentaries)

›
Abstract BACKGROUND :  Venous thromboembolism (VTE) often complicates the clinical course of cancer disease. The risk is ...
Thursday, January 26, 2012

open access: Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials

›

summary: Risk of Venous and Arterial Thromboembolic Events Associated With Anti-EGFR Agents: A Meta-Analysis of Randomized Clinical Trials - OncologySTAT

›
  SUMMARY OncologySTAT Editorial Team "Venous and arterial thromboembolism events (VTEs and ATEs) are common in patients wit...
Wednesday, January 04, 2012

Ovarian Failure, VTE Risks Added to Avastin Label - in Product Alert, Prescriptions from MedPage Today

›
Thursday, June 30, 2011

abstract: Cochrane Review - Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

›
BACKGROUND: Compared to patients without cancer, patients with cancer who receive anticoagulant treatment for venous thromboembolism a...
Wednesday, January 26, 2011

Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry (abstract)

›
Note: different adverse events depending on cancer site
Tuesday, September 14, 2010

Access : Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study (abstract)

›
Conclusions: Risk of VTE is higher among cancer patients than in the general population. Predictors of VTE include recency of cancer diagn...
Monday, September 13, 2010

Summary- Clinical burden of venous thromboembolism

›
Conclusions: Even among high-risk groups it is not possible to identify individuals who will go on to develop VTE, and, therefore, thrombo...
Saturday, February 06, 2010

When ‘never-events’ occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes

›
Note: ' never-events' is a term used in patient safety (eg. language - near misses, etc) Conclusions. "Women with CCC-O have...
Saturday, January 23, 2010

Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey): Findings in Surgical Patients

›
Note: study of data from 2004 "Use of prophylaxis varied according to major surgery type from 86.0% for orthopedic surgery to 53.8...